Top federal health officials say that psychedelics have “promising” therapeutic potential—but research into them has been stymied by ongoing federal prohibition. They also argue that as the Food and Drug Administration (FDA) considers approving substances like psilocybin, it’s important to look at issues such as accessibility, affordability, health care... Read more
A Democratic senator has refiled a bill that’s meant to lay the groundwork for federal marijuana legalization. Sen. John Hickenlooper (D-CO) introduced the legislation—titled the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (PREPARE) Act—on Thursday. The incremental reform would direct the attorney general to create a... Read more
Cannabis stocks began the year with a bounce that ended quickly with an all-time low set in June for the Global Cannabis Stock Index , but July was strong. The index rallied 13.1% to 8.48: The end of 2022 was challenging, with the index falling 23.7% in Q3 and 13.8% in Q4,... Read more
